TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,003 | -99.9% | 62,103 | -1.8% | 0.01% | +14.3% |
Q3 2022 | $796,000 | -8.3% | 63,248 | +6.7% | 0.01% | 0.0% |
Q2 2022 | $868,000 | -1.8% | 59,264 | -1.7% | 0.01% | +16.7% |
Q1 2022 | $884,000 | -1.6% | 60,262 | -2.6% | 0.01% | -14.3% |
Q4 2021 | $898,000 | -5.0% | 61,849 | -7.9% | 0.01% | +16.7% |
Q3 2021 | $945,000 | -70.4% | 67,150 | -65.1% | 0.01% | -68.4% |
Q2 2021 | $3,191,000 | -2.7% | 192,339 | +0.1% | 0.02% | -5.0% |
Q1 2021 | $3,278,000 | -2.6% | 192,099 | +3.4% | 0.02% | -4.8% |
Q4 2020 | $3,367,000 | +12.9% | 185,727 | +3.8% | 0.02% | -4.5% |
Q3 2020 | $2,982,000 | -5.2% | 178,968 | -0.8% | 0.02% | -8.3% |
Q2 2020 | $3,145,000 | +4.8% | 180,322 | +5.5% | 0.02% | -14.3% |
Q1 2020 | $3,001,000 | -13.5% | 170,925 | -3.4% | 0.03% | +7.7% |
Q4 2019 | $3,468,000 | +11.0% | 176,875 | -0.2% | 0.03% | +4.0% |
Q3 2019 | $3,125,000 | -1.8% | 177,302 | -3.1% | 0.02% | 0.0% |
Q2 2019 | $3,182,000 | -13.6% | 182,977 | -1.5% | 0.02% | -16.7% |
Q1 2019 | $3,681,000 | +85.3% | 185,800 | +88.9% | 0.03% | +76.5% |
Q4 2018 | $1,987,000 | – | 98,373 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |